🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Epirubicin + Ciclofosfamide + Fluorouracil + Paclitaxel

Found 56 matching trials

A Study of Trastuzumab Emtansine (Kadcyla) Plus Pertuzumab (Perjeta) Following Anthracyclines in Comparison With Trastuzumab (Herceptin) Plus Pertuzumab and a Taxane Following Anthracyclines as Adjuvant Therapy in Participants With Operable HER2-Positive Primary Breast Cancer

PHASE3

This two-arm, randomized, open-label, multicenter study will evaluate the e...

Status

Completed

Location

HonorHealth Research Institute - Bisgrove

Start Date

2014-01-31

Trial ID

NCT01966471

Treatments Being Tested

Trastuzumab Emtansine Trastuzumab Pertuzumab Paclitaxel Epirubicin Doxorubicin Docetaxel Cyclophosphamide 5-Fluorouracil

Evaluation of Differing Taxanes/Taxane Combinations on the Outcome of Patients With Operable Breast Cancer

PHASE1

Primary Objectives: * Determine the impact of each regimen on the disease ...

Status

Completed

Location

UT MD Anderson Cancer Center

Start Date

2002-11

Trial ID

NCT00050167

Treatments Being Tested

Paclitaxel Docetaxel Capecitabine

Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer

PHASE3

The efficacy of adjuvant chemotherapy is limited in patients with a high ri...

Status

Completed

Location

Hospital Universitario Virgen de los Lirios

Start Date

1999-11

Trial ID

NCT00129922

Treatments Being Tested

paclitaxel Fluorouracil Epirubicin Cyclophosphamide

Adjuvant 6 Cycles of Docetaxel and Cyclophosphamide or 3 Cycles of Cyclophosphamide/Epirubicin/Fluorouracil Followed by 3 Cycles of Docetaxel Versus 4 Cycles of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel in Operable Breast Cancer (MASTER)

PHASE3

We aimed to evaluate the noninferiority of a short-term anthracycline-free ...

Status

Completed

Location

Multiple Locations

Start Date

2010-06-01

Trial ID

NCT04127019

Treatments Being Tested

Paclitaxel Docetaxel Cyclophosphamide Epirubicin 5-fluorouracil

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

PHASE3

Primary aim: To compare the effect on pathologic complete response (pCR) ra...

Status

Active Not Recruiting

Location

Vejle Hospital

Start Date

2019-12-20

Trial ID

NCT04335669

Treatments Being Tested

epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab

MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I

PHASE4

Genomics assays that measure specific gene expression patterns in a patient...

Status

Completed

Location

University of South Alabama, Mitchell Cancer Institute

Start Date

2011-10

Trial ID

NCT01501487

Treatments Being Tested

TAC chemotherapy TC chemotherapy Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemotherapy TCH chemotherapy T + trastuzumab followed by CEF + trastuzumab Dose dense AC followed by T + trastuzumab Dose dense AC followed by T + trastuzumab + pertuzumab PTH followed by dose dense AC of FEC

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

PHASE2

This study will examine safety and efficacy of Lapatinib in combination wit...

Status

Completed

Location

GSK Investigational Site

Start Date

2007-08

Trial ID

NCT00524303

Treatments Being Tested

Trastuzumab Paclitaxel FEC75 Lapatinib

Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

PHASE3

This study that aims to evaluate the addition of MPDL3280A (atezolizumab) t...

Status

Completed

Location

Brustgesundheitzentrum Tirol, Univ. Frauenklinik Innsbruck

Start Date

2016-04

Trial ID

NCT02620280

Treatments Being Tested

Carboplatin Abraxane MPDL3280A Surgery Anthra

SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer

PHASE2

Open label multicentric phase II randomized trial, using high throughput ge...

Status

Active Not Recruiting

Location

Institut de Cancérologie de l'Ouest/Paul Papin

Start Date

2014-04-07

Trial ID

NCT02299999

Treatments Being Tested

AZD2014 AZD4547 AZD5363 AZD8931 Selumetinib Vandetanib Bicalutamide Olaparib Anthracyclines Taxanes cyclophosphamide DNA intercalators Methotrexate vinca alkaloids Platinum based chemotherapies Bevacizumab Mitomycin C Eribulin MEDI4736

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2

PHASE3

This study compares two schedules of upfront chemotherapy in HER positive b...

Status

Active Not Recruiting

Location

Jeroen Bosch Hospital

Start Date

2013-12

Trial ID

NCT01996267

Treatments Being Tested

PTC+Pertuzumab FEC-T+Pertuzumab

Previous Next